Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder
Launched by NORTHWESTERN UNIVERSITY · Jul 9, 2015
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Prospective volunteers will be screened by phone and, if eligible, invited to a clinical evaluation in the laboratory, located at Northwestern University. At the laboratory, prospective volunteers complete written informed consent and learn about the study.
All evaluations will measure the following variables: Anhedonia will be assessed using the Snaith-Hamilton Pleasure Scale, Temporal Experience of Pleasure Scale, and Effort-Expenditure for Rewards Task; Mood symptoms will be assessed by the Structured Clinical Interview for DSM-IV, Inventory of Depressive Symptomatology-Clinician Versio...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Currently experiencing a score ≥ 20 on a clinician-administered scale of anhedonia
- • Currently experiencing two or more symptoms of depression with bipolar disorder either Type I or II (one of these symptoms should be anhedonia) OR
- • Currently experiencing two or more symptoms of unipolar depression, without current psychotic features (one of these symptoms should be anhedonia)
- • Currently on a medication for a mood disorder
- • Proficiency in English
- • Able to provide informed consent
- Exclusion Criteria:
- • Current psychosis (schizoaffective, schizophreniform, delusional disorder)
- • Current suicide risk sufficient to preclude treatment on an outpatient basis
- • Severe, unstable concurrent psychiatric conditions likely to require hospitalization within six months (ex. hazardous substance use evidenced by a score \> 10 on the Alcohol Use Disorders Identification Test or \> 2 on the Drug Use Disorders identification Test)
- • Current incarcerated or on probation due to criminal allegations
- • Currently pregnant
- • Cognitive impairment
- • Those living in the United States on a VISA
- • Those currently in psychotherapy
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Jackie K Gollan, Ph.D.
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials